SRPT logo

Sarepta Therapeutics (SRPT) Working capital

annual working capital:

$2.34B+$416.11M(+21.61%)
December 31, 2024

Summary

  • As of today (May 29, 2025), SRPT annual working capital is $2.34 billion, with the most recent change of +$416.11 million (+21.61%) on December 31, 2024.
  • During the last 3 years, SRPT annual working capital has risen by +$190.41 million (+8.85%).
  • SRPT annual working capital is now at all-time high.

Performance

SRPT Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTbalance sheet metrics

quarterly working capital:

$1.83B-$514.83M(-21.98%)
March 1, 2025

Summary

  • As of today (May 29, 2025), SRPT quarterly working capital is $1.83 billion, with the most recent change of -$514.83 million (-21.98%) on March 1, 2025.
  • Over the past year, SRPT quarterly working capital has dropped by -$29.21 million (-1.57%).
  • SRPT quarterly working capital is now -21.98% below its all-time high of $2.34 billion, reached on December 31, 2024.

Performance

SRPT quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

SRPT Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+21.6%-1.6%
3 y3 years+8.8%-12.0%
5 y5 years+94.5%-18.5%

SRPT Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+21.6%-22.0%at low
5 y5-yearat high+94.5%-22.0%+0.8%
alltimeall timeat high>+9999.0%-22.0%>+9999.0%

SRPT Working capital History

DateAnnualQuarterly
Mar 2025
-
$1.83B(-22.0%)
Dec 2024
$2.34B(+21.6%)
$2.34B(+17.9%)
Sep 2024
-
$1.99B(-0.5%)
Jun 2024
-
$2.00B(+7.5%)
Mar 2024
-
$1.86B(-3.6%)
Dec 2023
$1.93B(-0.6%)
$1.93B(-3.7%)
Sep 2023
-
$2.00B(+1.3%)
Jun 2023
-
$1.97B(+1.2%)
Mar 2023
-
$1.95B(+0.7%)
Dec 2022
$1.94B(-9.9%)
$1.94B(-4.2%)
Sep 2022
-
$2.02B(+5.2%)
Jun 2022
-
$1.92B(-7.3%)
Mar 2022
-
$2.08B(-3.5%)
Dec 2021
$2.15B(+4.0%)
$2.15B(+18.7%)
Sep 2021
-
$1.81B(-1.5%)
Jun 2021
-
$1.84B(-3.5%)
Mar 2021
-
$1.91B(-7.9%)
Dec 2020
$2.07B(+71.8%)
$2.07B(+6.4%)
Sep 2020
-
$1.94B(-7.6%)
Jun 2020
-
$2.10B(-6.1%)
Mar 2020
-
$2.24B(+86.1%)
Dec 2019
$1.20B(-3.9%)
$1.20B(+5.0%)
Sep 2019
-
$1.15B(-9.4%)
Jun 2019
-
$1.27B(-17.5%)
Mar 2019
-
$1.53B(+22.5%)
Dec 2018
$1.25B(+9.8%)
$1.25B(+39.5%)
Sep 2018
-
$897.68M(-13.2%)
Jun 2018
-
$1.03B(-8.3%)
Mar 2018
-
$1.13B(-1.1%)
Dec 2017
$1.14B(+282.6%)
$1.14B(+71.4%)
Sep 2017
-
$665.14M(+104.9%)
Jun 2017
-
$324.63M(-15.2%)
Mar 2017
-
$382.68M(+28.4%)
Dec 2016
$298.05M(+83.7%)
$298.05M(-19.4%)
Sep 2016
-
$369.81M(+328.7%)
Jun 2016
-
$86.26M(-18.3%)
Mar 2016
-
$105.57M(-34.9%)
Dec 2015
$162.25M(-23.1%)
$162.25M(+92.1%)
Sep 2015
-
$84.44M(-41.1%)
Jun 2015
-
$143.43M(-9.9%)
Mar 2015
-
$159.14M(-24.6%)
Dec 2014
$210.93M(-10.2%)
$210.93M(-14.6%)
Sep 2014
-
$247.09M(-10.2%)
Jun 2014
-
$275.27M(+30.1%)
Mar 2014
-
$211.61M(-9.9%)
Dec 2013
$234.84M(+104.2%)
$234.84M(-1.9%)
Sep 2013
-
$239.32M(+197.4%)
Jun 2013
-
$80.47M(+10.3%)
Mar 2013
-
$72.94M(-36.6%)
Dec 2012
$115.02M(+367.9%)
$115.02M(-982.0%)
Sep 2012
-
-$13.04M(-181.0%)
Jun 2012
-
$16.10M(+108.9%)
Mar 2012
-
$7.71M(-68.6%)
Dec 2011
$24.58M(-406.6%)
$24.58M(-3.3%)
Sep 2011
-
$25.41M(-12.6%)
Jun 2011
-
$29.09M(-715.6%)
Mar 2011
-
-$4.72M(-41.1%)
DateAnnualQuarterly
Dec 2010
-$8.02M(-145.0%)
-$8.02M(+452.7%)
Sep 2010
-
-$1.45M(-154.5%)
Jun 2010
-
$2.66M(-85.0%)
Mar 2010
-
$17.81M(+0.0%)
Dec 2009
$17.80M(+82.5%)
$17.80M(+28.2%)
Sep 2009
-
$13.89M(-808.9%)
Jun 2009
-
-$1.96M(-111.4%)
Mar 2009
-
$17.16M(+75.9%)
Dec 2008
$9.76M(-48.5%)
$9.76M(+8.5%)
Sep 2008
-
$8.99M(-34.4%)
Jun 2008
-
$13.72M(+3.8%)
Mar 2008
-
$13.22M(-30.3%)
Dec 2007
$18.96M(-38.4%)
$18.96M(+163.2%)
Sep 2007
-
$7.20M(-55.9%)
Jun 2007
-
$16.33M(-31.9%)
Mar 2007
-
$23.96M(-22.2%)
Dec 2006
$30.79M(-32.9%)
$30.79M(-17.0%)
Sep 2006
-
$37.11M(-13.4%)
Jun 2006
-
$42.84M(-11.8%)
Mar 2006
-
$48.56M(+5.8%)
Dec 2005
$45.91M(+155.8%)
$45.91M(+58.4%)
Sep 2005
-
$28.98M(-5.0%)
Jun 2005
-
$30.50M(-13.3%)
Mar 2005
-
$35.20M(+96.1%)
Dec 2004
$17.95M(-48.2%)
$17.95M(-20.1%)
Sep 2004
-
$22.45M(-18.3%)
Jun 2004
-
$27.48M(-20.1%)
Mar 2004
-
$34.41M(-0.7%)
Dec 2003
$34.64M(+126.7%)
$34.64M(+33.2%)
Sep 2003
-
$26.01M(-11.8%)
Jun 2003
-
$29.48M(+169.0%)
Mar 2003
-
$10.96M(-28.3%)
Dec 2002
$15.28M(-36.9%)
$15.28M(-15.6%)
Sep 2002
-
$18.11M(-31.2%)
Jun 2002
-
$26.31M(-21.2%)
Mar 2002
-
$33.38M(+37.8%)
Dec 2001
$24.23M(-22.9%)
$24.23M(-11.0%)
Sep 2001
-
$27.24M(-20.5%)
Jun 2001
-
$34.25M(+32.4%)
Mar 2001
-
$25.86M(-17.7%)
Dec 2000
$31.41M(+193.5%)
$31.41M(-15.0%)
Sep 2000
-
$36.95M(+289.3%)
Jun 2000
-
$9.49M(-30.5%)
Mar 2000
-
$13.66M(+27.7%)
Dec 1999
$10.70M(+37.2%)
$10.70M(+529.4%)
Sep 1999
-
$1.70M(-57.5%)
Jun 1999
-
$4.00M(-33.3%)
Mar 1999
-
$6.00M(-23.1%)
Dec 1998
$7.80M(-54.7%)
$7.80M(-24.3%)
Sep 1998
-
$10.30M(-27.0%)
Jun 1998
-
$14.10M(-10.8%)
Mar 1998
-
$15.80M(-8.1%)
Dec 1997
$17.20M(+537.0%)
$17.20M(-2.8%)
Sep 1997
-
$17.70M(+6.0%)
Jun 1997
-
$16.70M(+778.9%)
Mar 1997
-
$1.90M
Dec 1996
$2.70M
-

FAQ

  • What is Sarepta Therapeutics annual working capital?
  • What is the all time high annual working capital for Sarepta Therapeutics?
  • What is Sarepta Therapeutics annual working capital year-on-year change?
  • What is Sarepta Therapeutics quarterly working capital?
  • What is the all time high quarterly working capital for Sarepta Therapeutics?
  • What is Sarepta Therapeutics quarterly working capital year-on-year change?

What is Sarepta Therapeutics annual working capital?

The current annual working capital of SRPT is $2.34B

What is the all time high annual working capital for Sarepta Therapeutics?

Sarepta Therapeutics all-time high annual working capital is $2.34B

What is Sarepta Therapeutics annual working capital year-on-year change?

Over the past year, SRPT annual working capital has changed by +$416.11M (+21.61%)

What is Sarepta Therapeutics quarterly working capital?

The current quarterly working capital of SRPT is $1.83B

What is the all time high quarterly working capital for Sarepta Therapeutics?

Sarepta Therapeutics all-time high quarterly working capital is $2.34B

What is Sarepta Therapeutics quarterly working capital year-on-year change?

Over the past year, SRPT quarterly working capital has changed by -$29.21M (-1.57%)
On this page